Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LDLRAD4 antisense RNA 2 is a human long non-coding antisense RNA gene located at the LDLRAD4 (low density lipoprotein receptor class A domain containing 4) locus on chromosome 18. It is catalogued by the Alliance of Genome Resources (HGNC:58069) and does not encode a protein. The molecule is not currently linked to specific biological functions or diseases, nor is it considered a canonical receptor, enzyme, transporter, or standard drug target. Its regulatory role is inferred from its classification as an antisense lncRNA, with possible involvement in gene expression regulation or epigenetic processes, but functional characterization is lacking[4]. If more detailed functional studies or disease data emerge, these fields should be updated.
There are no drugs or therapies targeting LDLRAD4-AS2, so mechanisms of action are not established
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on LDLRAD4 antisense RNA 2 (LDLRAD4-AS2).